Evolution of COVID-19 Pulmonary Fibrosis–Like Residual Changes Over Time — Longitudinal Chest CT up to 9 Months After Disease Onset: a Single-Center Case Series
Abstract The aim of the study was to evaluate the temporal evolution of fibrotic-like pulmonary interstitial abnormalities secondary to Sars-CoV-2 virus (COVID-19) pneumonia detected on chest-CTs of patients hospitalized for COVID-19 infection. We retrospectively reviewed chest-CTs obtained up to 9 months after disease onset in a group of patients with COVID-19 pneumonia and CT features suggestive of lung fibrosis at the first follow-up after hospital discharge. We observed a complete and unexpected resolution of all interstitial abnormalities, including reticulations and bronchial dilatation, in a period of about 6–9 months after discharge. Interstitial fibrotic-like changes detectable in the first months after COVID-19 pneumonia could be slowly or very slowly resolving but still completely reversible and probably secondary to an organizing pneumonia reaction..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
SN comprehensive clinical medicine - 4(2022), 1 vom: 14. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Poerio, Antonio [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 |
|---|
| doi: |
10.1007/s42399-022-01140-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR046237763 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR046237763 | ||
| 003 | DE-627 | ||
| 005 | 20230519204637.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220215s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s42399-022-01140-1 |2 doi | |
| 035 | |a (DE-627)SPR046237763 | ||
| 035 | |a (SPR)s42399-022-01140-1-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Poerio, Antonio |e verfasserin |0 (orcid)0000-0001-6890-9278 |4 aut | |
| 245 | 1 | 0 | |a Evolution of COVID-19 Pulmonary Fibrosis–Like Residual Changes Over Time — Longitudinal Chest CT up to 9 Months After Disease Onset: a Single-Center Case Series |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 | ||
| 520 | |a Abstract The aim of the study was to evaluate the temporal evolution of fibrotic-like pulmonary interstitial abnormalities secondary to Sars-CoV-2 virus (COVID-19) pneumonia detected on chest-CTs of patients hospitalized for COVID-19 infection. We retrospectively reviewed chest-CTs obtained up to 9 months after disease onset in a group of patients with COVID-19 pneumonia and CT features suggestive of lung fibrosis at the first follow-up after hospital discharge. We observed a complete and unexpected resolution of all interstitial abnormalities, including reticulations and bronchial dilatation, in a period of about 6–9 months after discharge. Interstitial fibrotic-like changes detectable in the first months after COVID-19 pneumonia could be slowly or very slowly resolving but still completely reversible and probably secondary to an organizing pneumonia reaction. | ||
| 650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Diffuse lung disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Organizing pneumonia |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pulmonary fibrosis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a HRCT |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Carlicchi, Eleonora |4 aut | |
| 700 | 1 | |a Lotrecchiano, Ludovica |4 aut | |
| 700 | 1 | |a Praticò, Chiara |4 aut | |
| 700 | 1 | |a Mistè, Giacomo |4 aut | |
| 700 | 1 | |a Scavello, Saverio |4 aut | |
| 700 | 1 | |a Morsiani, Miria |4 aut | |
| 700 | 1 | |a Zompatori, Maurizio |4 aut | |
| 700 | 1 | |a Ferrari, Rodolfo |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t SN comprehensive clinical medicine |d [Cham] : Springer International Publishing, 2019 |g 4(2022), 1 vom: 14. Feb. |w (DE-627)SPR038535785 |w (DE-600)2947252-0 |x 2523-8973 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2022 |g number:1 |g day:14 |g month:02 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s42399-022-01140-1 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2022 |e 1 |b 14 |c 02 | ||